期刊文献+

CD40抗体——一种新型免疫佐剂的机制及应用研究进展 被引量:2

下载PDF
导出
摘要 抗体是基础生命科学研究领域不可或缺的工具。CD40信号转导通路参与了抗体的合成与分泌,抗CD40抗体可通过激活CD40信号通路,极大地增强抗原尤其是半抗原的免疫原性,是一种新型、有潜能的免疫佐剂,并且其抗原表达与抗体制备过程相对简单、毒性小,可用于常规免疫和疫苗的生产。本文综述了抗CD40抗体佐剂的特性、作用机理及其影响因素和应用。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2014年第3期329-332,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(81160200,81060135,30860263)
  • 相关文献

参考文献31

  • 1余坚,赵飞骏,吴移谋.核酸疫苗佐剂的研究进展[J].微生物学免疫学进展,2010,38(3):61-66. 被引量:2
  • 2Vonderheide RH,Burg JM,Mick R. Phase Ⅰ study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors[J].Oncoimmunology,2013,(01):e23033.
  • 3Gladue RP,Paradis T,Cole SH. The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice[J].{H}Cancer Immunology lmmunotherapy,2011,(07):1009-1017.
  • 4Xu H,Zhao G,Huang X. CD40-expressing plasmid induces antiCD40 antibody and enhances immune responses to DNA vaccination[J].{H}Journal of Gene Medicine,2010,(01):97-106.
  • 5Rycyzyn MA,Staquet K,Fisher J. The use of anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation[J].{H}HYBRIDOMA,2008,(01):25-30.
  • 6罗龙龙,张彦,侯春梅,乔春霞,黎燕.抗CD40单克隆抗体研究进展[J].中国实验血液学杂志,2013,21(2):508-512. 被引量:3
  • 7Hunter TB,Alsarraj M,Gladue RP. An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell/lymph node cell model[J].{H}Scandinavian Journal of Immunology,2007,(05):479-486.
  • 8Barr T,Carlring J,Heath A. Co-stimulatory agonists as immunological adjuvants[J].{H}VACCINE,2006,(17):3399-3407.doi:10.1016/j.vaccine.2006.02.022.
  • 9Barr TA,McCormick AL,Carlring J. A potent adjuvant effect of CD40 antibody attached to antigen[J].{H}IMMUNOLOGY,2003,(01):87-92.
  • 10Zhou ZH,Wang JF,Wang YD. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line[J].{H}HYBRIDOMA,1999,(06):471-478.

二级参考文献25

共引文献29

同被引文献29

  • 1曾振,王海宁,张志芳,易咏竹.新型疫苗佐剂的研究进展[J].生物工程学报,2021,37(1):78-87. 被引量:16
  • 2周晨阳,刘海燕,杨发龙.新型免疫佐剂研究进展[J].现代畜牧兽医,2007(5):76-78. 被引量:4
  • 3Xing X, Lian S, Hu Y, et al. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma[ J/OL]. J Transl Med, 2013, 11 ( 1 ) : 309.
  • 4Rios P, Li X, Kfhn M. Molecular mechanisms of the PRL phosphatases [J]. FEBS J, 2013, 280 (2) : 505 -524.
  • 5Peng L, Xing X, Li W, et al. PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin betal-ERK1/2 and-MMP2 signaling[ J/OL]. Mol Cancer, 2009, 8: 110.
  • 6Guzika-Ustymowicz K, Kiluk J, Tertikowski SJ, et al. Expression of phosphatase of regenerating liver-3 ( PRL-3 ) in endometrioid cancer and lymph nodes metastases[ J/OA]. Adv Med Sei, 2013, 58(2): 221 - 226.
  • 7Peng L, Li Y, Meng L, et al. Preparation and characterization of monoelonal antibody against protein tyrosine phosphatase PRL-3 [ J ]. Hybrid Hybridomics, 2004, 23 ( 1 ) : 23 - 27.
  • 8Jiang J, Xie D, Zhang W, et al. Fusion of Hsp70 to Mage-al enhances the potency of vaccine-specific immune responses[ J/OL]. J Transl Med, 2013, 11 ( 1 ) : 300.
  • 9Romln E, MorenoC. Synthetic peptides non-covalently bound to bacterial hspT0 elicit peptide-specific T-cell responses in vivo [ J ]. Immunology, 1996, 88(4) : 487 -492.
  • 10Suzue K, Young RA. Adjuvant-free hspT0 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24 [ J ]. J Immunol, 1996, 156(2) : 873 -879.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部